Stocks
Allogene Therapeutics (ALLO) OCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -137.4 | -115.1 | -184.8 | -220.5 | -237.7 | -217.3 | ||
| Changes by years, y/y, % | +208% | -16% | +61% | +19% | +8% | +39.7% | |||
Allogene Therapeutics. OCF, bln rub
Allogene Therapeutics. OCF, changes, %
Allogene Therapeutics. OCF, sum by quarters, bln rub
Allogene Therapeutics (ALLO) OCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| OCF, bln rub | ? | -55.5 | -53.7 | -55.9 | -63.6 | -44.1 | -217.3 | |
| Changes by years, y/y, % | +17% | -14% | -16% | +3% | -21% | |||
| Changes by quarters, q/q, % | -10% | -3% | +4% | +14% | -31% | |||
